Press ReleasesMar 18, 2025Helix Launches 23,000-Patient Clinico-Genomic Cohort for Autoimmune Diseases to Advance Drug Discovery and Development
WebinarsMar 6, 2025Metabolic risk factors and BMI-associated variants influencing weight loss with Semaglutide
Press ReleasesFeb 3, 2025Helix Launches World's Largest Clinico-Genomic Cohort of GLP-1 Agonist Treated Patients
Press ReleasesJan 13, 2025Helix Partners with Komodo Health, Combining Helix's Clinico-Genomic Datasets with Komodo's Healthcare Map® for Clinical & Research Impact
Press ReleasesNov 13, 2024Helix Debuts Novel Precision Effectiveness Model That Predicts 12-Month Weight Loss Response of Semaglutide in Diverse Populations
ResearchNov 4, 2024A novel method for predicting Lp(a) levels from routine outpatient genomic testing identifies those at risk of cardiovascular disease across a diverse cohort
Press ReleasesOct 30, 2024Helix to Showcase the Impact of Clinico-Genomic Research on Clinical Care and Drug Discovery at ASHG Annual Meeting